Delivering On Promises For 

Complete outsourcing across Europe and emerging markets.

Years

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

,

From Early Development

Our early development experts implement validated techniques and best-in-class strategies to generate data for decisive milestones and decision-making during this critical phase of your product’s development.

Add to that formula our Early Phase Unit BIO1, allowing Biomapas to cover all types of early phase clinical studies, including first-in-human and proof-of-concept, single and multiple doses, bioequivalence, bioavailability, drug-drug and drug-food interaction, PK/PD, tQTc studies. 

,

To Marketing Authorization

With a strong presence across Eastern Europe and the CIS region we can accelerate your Clinical Development. In these regions patient recruitment is fast and reliable, and investigators are keen to participate in trials thanks to less competition and more treatment naïve patients.

We provide full-service solutions for Phase I-IV clinical research and medical devices. We have clinical experts in over 20 countries and experience in the broad spectrum of therapeutic areas.

 

,

And Commercial Success

Marketed products are continuously subject to change so, Biomapas’ services continue beyond Marketing Authorization. Partnering with you to ensure you meet Post-Authorization requirements regarding your product’s quality and safety throughout its lifecycle. 

Our teams are fit to handle large Post-Authorization compliance requirements  integrating our Pharmacovigilance, Medical Information, and Regulatory Affairs services and working efficiently as a multi-disciplinary team.

Clinical Research

Leading the way in combining quality and effciency, we are particularly strongly positioned in Eastern Europe and the Baltics. The region where patient recruitment is fast, reliable, and jnvestigators are keen to participate in trials.

Regulatory Affairs

Local regulatory experts for Pharma, Biotech and Medical Device companies across Europe and emerging markets from dossier development to full life-cycle management.​

Pharmacovigilance

Solid extension of Pharma and Biotech safety team for both full PV system and local safety network across Europe and emerging markets (CIS & EAEU).

Medical Information

Trusted, highly engaged MI partner for Pharma, Biotech and Medical Device companies, delivering excellence and ensuring compliance across Europe, CIS and USA throughout the entire product life-cycle.

The passion and experience of our people ensures timely execution every time. – Audrius Sveikata, MD, PhD. CEO & Co-Founder

bi_audrius_sveikata

We keep Promises. Always.

Biomapas is a functional and full outsourcing solution provider to the global life science industry. As a trusted partner for biopharma, we have one-stop-shop clinical research capabilities in high recruiting countries, delivering regulatory and pharmacovigilance excellence across Europe and emerging markets through the entire product lifecycle. We ensure clients satisfaction by rapid, efficient and cost-effective working practices.

Flexible solutions regardless of where you are in development.

Meeting timelines and milestones is critical to move your development program forward while keeping the goal in mind. Our in-house experience combined with a hands-on mindset allows for tailored solutions to complicated challenges that emerge on your path to commercialization. Biomapas’ professionals execute your projects efficiently, cost-effectively and aspire to partner with you and become an integral part of your team from Early Development to Commercial success.

Why work with us? 

Our  teams have comprehensive expertise and assure quality and accuracy for all our activities across a broad region. We have colleagues spread through all European regions and the Emerging Markets.

All team highly educated Life Sciences professionals have a track record of exceeding our clients’ expectations.

 

 

Global Reach

Recurring Customers

%

Getting in touch

6 + 6 =

Contact us to learn about how we can accelerate your clinical development, accelerate your path to Market Authorization, and ensure compliance with local and global Post-Marketing requirements.

Or meet us at an upcoming event

DIA Euromeeting

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

BIO Europe Spring

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

From development

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

Clinical

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.

To commercialization

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.